Ceftriaxone Dosing for Community-Acquired Pneumonia
For otherwise healthy adults with community-acquired pneumonia and normal renal function, use ceftriaxone 1 gram IV daily; no dose adjustment is needed in renal impairment up to 2 grams daily. 1
Standard Dosing in Adults with Normal Renal Function
The FDA-approved dosing for adults is 1 to 2 grams given once daily (or in equally divided doses twice daily) depending on infection type and severity, with a maximum daily dose of 4 grams 1. For CAP specifically:
- Outpatient-equivalent or moderate CAP: 1 gram IV daily is sufficient
- Severe CAP requiring ICU admission: Consider 2 grams IV daily
The 2019 IDSA/ATS CAP guidelines do not specify ceftriaxone dosing explicitly, but recommend beta-lactam therapy as part of combination regimens for hospitalized patients 2.
Evidence Supporting 1 Gram Daily Dosing
Recent high-quality evidence strongly supports 1 gram daily as adequate for most CAP cases:
- A 2025 Japanese nationwide study of 471,694 pneumonia patients found no mortality difference between 1 g/day versus 2 g/day (4.6% vs 4.5%, p=0.219), with 1 g/day showing lower rates of C. difficile infection 3
- A 2023 Israeli cohort of 3,989 CAP patients demonstrated equivalent 30-day mortality (14.7% vs 16.0%, p=0.24) with 1 g/day, plus significantly reduced CDI rates (0.2% vs 0.6%, p=0.03) and shorter hospital stays 4
- A 2019 meta-analysis confirmed that 1 g daily regimens are as safe and effective as higher doses for CAP (OR 1.02,95% CI 0.91-1.14) 5
Exception: Severe Pneumonia Requiring Mechanical Ventilation
For patients requiring mechanical ventilation, use 2 grams IV daily. The 2025 Japanese study found that in this critically ill subgroup, 2 g/day was associated with significantly lower 30-day mortality (17.2% vs 20.4%; risk difference -3.2%, p=0.006) 3.
Dosing in Renal Impairment
No dose adjustment is necessary for renal impairment when using standard doses up to 2 grams daily 1. This is a critical advantage of ceftriaxone:
- Ceftriaxone has dual elimination (33-67% renal, remainder biliary) 1
- In end-stage renal disease (CrCl <15 mL/min), half-life increases modestly to 15.6 hours versus 5.8-8.7 hours in normal function 6
- Even in functionally anephric patients with normal hepatic function, half-life only increases to ~12 hours 7
- Hemodialysis does not significantly remove ceftriaxone 1
The FDA label explicitly states: "No dosage adjustment is necessary for patients with impairment of renal or hepatic function" up to 2 grams daily 1.
Dosing Algorithm by Renal Function
For empirical CAP treatment, a 2026 pharmacokinetic study suggests:
- eGFR >60 mL/min/1.73 m²: 1 gram IV every 12 hours (to maintain adequate free drug concentrations)
- eGFR ≤60 mL/min/1.73 m²: 1 gram IV every 24 hours 8
However, this conflicts with FDA guidance and most clinical practice. In real-world practice, 1-2 grams once daily is used regardless of renal function for standard CAP, with the FDA label supporting this approach 1.
Administration Details
- Infusion time: Administer IV over 30 minutes in adults 1
- Concentration: 10-40 mg/mL recommended 1
- Duration: Continue for at least 2 days after clinical improvement; typical duration 4-14 days 1
Important Caveats
- Geographic resistance patterns matter: These recommendations assume low prevalence of drug-resistant Streptococcus pneumoniae. In areas with high resistance, higher doses may be needed 4
- Always add macrolide coverage: For hospitalized CAP, ceftriaxone should be combined with azithromycin or doxycycline per IDSA/ATS guidelines 2
- Avoid calcium-containing solutions: Do not mix with or administer sequentially without line flushing due to precipitation risk 1
- Monitor for C. difficile: Higher doses (2 g/day) carry increased CDI risk 3, 4